This comment in the press release today suggests to me that Rock Creek might be exploring licensing opportunities in Japan.
"Numerous Japanese companies in-license drugs and compounds from overseas for development in Japan."
Now that Rock Creek has a patent granted, I bet that would change negotiations significantly. Perhaps a bidding war to license in Japan might occur?
I agree. Wouldn't it be something if anatabloc resurfaces in Japan?
Did you also see the comment about animal inflammatory disease?
Is that a hint of a new product for the veterinary market?
Back when anatabloc was being sold in the US, I remember people reporting they were giving it to their pets for arthritis.